Alzheimer Disease Clinical Trial
— MILLSOfficial title:
Training the Long-Term Services and Supports Dementia Care Workforce in Provision of Care to Sexual and Gender Minority Residents
This study is designed to help improve the care of sexual and gender minority (SGM) with Alzheimer's Disease and Alzheimer's Disease Related Dementia (AD/ADRD) in long-term services and supports (LTSS) by training the state's LTSS workforce in SGM culturally responsive care. The randomized controlled trial will rigorously test the effects of an in person versus an online training program on improving SGM culturally responsive care with a waitlist control.
Status | Recruiting |
Enrollment | 760 |
Est. completion date | July 4, 2026 |
Est. primary completion date | April 21, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - licensure in Minnesota to provide nursing and/or as a housing with services establishment - Willingness to undertake a policy and environment review at baseline and 6 months later - having at least 5 managers/ supervisors and 5 staff. Exclusion Criteria: - Participants who cannot speak and read English |
Country | Name | City | State |
---|---|---|---|
United States | University of Minnesota | Minneapolis | Minnesota |
Lead Sponsor | Collaborator |
---|---|
University of Minnesota | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Discrimination experience at work | Adapted everyday discrimination scale | Baseline | |
Other | Discrimination experience at work | Adapted everyday discrimination scale | immediately post-intervention | |
Other | Discrimination experience at work | Adapted everyday discrimination scale | 6 months post-intervention | |
Other | Social desirability at work | Marlowe Crowne Social desirability scale | Baseline | |
Other | Social desirability at work | Marlowe Crowne Social desirability scale | immediately post-intervention | |
Other | Social desirability at work | Marlowe Crowne Social desirability scale | 6 months post-intervention | |
Other | Sexual and Religious Identification | Duke Religiosity Index | Baseline | |
Other | Sexual and Religious Identification | Duke Religiosity Index | 6 months follow-up post-intervention | |
Other | Agency demographics | Agency type, size and staff | Baseline | |
Other | SGM estimate | Number of SGM staff | Baseline and 6 month follow up. | |
Other | SGM estimate | Number of SGM staff | 6 months follow up post-intervention | |
Primary | Environment change | Access to sexual and gender minority (SGM) providers, gender neutral intake forms | baseline and 6-months follow up | |
Primary | Skills assessment | Ability to conduct 7 skills key to providing competent care to SGM | Baseline | |
Primary | Skills assessment | Ability to conduct 7 skills key to providing competent care to SGM | Immediately post-intervention | |
Primary | Competence in SGM Care | Competent scale when it comes to providing care to SGM | 6 months after intervention | |
Secondary | SGM with AD/ADRD referenced explicitly in policies | Human Resources policies and intake forms | Baseline | |
Secondary | SGM with AD/ADRD referenced explicitly in policies | HR policies and intake forms | 6 months post-intervention | |
Secondary | SGM knowledge | 10-item review of key content in training | Baseline | |
Secondary | SGM knowledge | 10-item review of key content in training | immediately post-intervention | |
Secondary | SGM knowledge | 10-item review of key content in training | 6 months post-intervention | |
Secondary | SGM attitudes | Homonegativity scale | Baseline | |
Secondary | SGM attitudes | Homonegativity scale | immediately post-intervention | |
Secondary | SGM attitudes | Homonegativity scale | 6 months post-intervention | |
Secondary | Health care empathy | Jefferson Physician Empathy student version | Baseline | |
Secondary | Health care empathy | Jefferson Physician Empathy student version | immediately post-intervention | |
Secondary | Health care empathy | Jefferson Physician Empathy student version | 6 months post-intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |